Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Barradas

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
American Journal of Clinical Pathology|June 1, 1986
Bleeding disorder associated with albumin-dependent partial deficiency in platelet thromboxane productionD P Mikhailidis, M A Barradas, P Dandona
Thrombosis Research|June 1, 1986
Heparin-induced platelet aggregation is inhibited by antagonists of the thromboxane pathwayD P Mikhailidis, M A Barradas, P Dandona
Diabetic Medicine : a Journal of the British Diabetic Association|September 1, 1985
Platelet aggregation in diabetics using the new electronic platelet aggregometerD P Mikhailidis, M A Barradas, P Dandona
Journal of Clinical Pathology|March 1, 1986
Fibrinogen mediated activation of platelet aggregationD P Mikhailidis, M A Barradas, P Dandona
Journal of the Royal Society of Medicine|January 1, 1987
Cardiovascular risk in patients with treated familial hypercholesterolaemia and patients with severe hypertriglyceridaemiaD P Mikhailidis, M A Barradas, P Dandona
Thrombosis and Haemostasis|December 17, 1985
Dihomo-gamma-linolenic acid in patients with atherosclerosis: effects on platelet aggregation, plasma lipids and low-density lipoprotein-induced inhibition of prostacyclin generationD P Mikhailidis, M A Barradas, P Dandona
In Vivo (Athens, Greece)|November 1, 1992
Measurement of platelet volume using a channelyzer: assessment of the effect of agonists and antagonistsM A Barradas, S O'Donoghue, D P Mikhailidis
Diabetes Research and Clinical Practice|January 1, 1987
The effect of non-esterified fatty acids on vascular ADP-degrading enzyme activityM A Barradas, D P Mikhailidis, P Dandona
British Journal of Clinical Pharmacology|February 1, 1996
A low molecular weight heparin, nadroparin (Fraxiparine), inhibits thrombin-induced platelet shape change and does not enhance spontaneous platelet aggregationI A Jagroop, M A Barradas, D P Mikhailidis
Platelets|November 4, 2010
Platelet hyperactivity: a predictor of cardiac events and death from myocardial infarctionD P Mikhailidis, M A Barradas, J Y Jeremy
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
American Journal of Clinical Pathology|June 1, 1986
Bleeding disorder associated with albumin-dependent partial deficiency in platelet thromboxane productionD P Mikhailidis, M A Barradas, P Dandona
Thrombosis Research|June 1, 1986
Heparin-induced platelet aggregation is inhibited by antagonists of the thromboxane pathwayD P Mikhailidis, M A Barradas, P Dandona
Diabetic Medicine : a Journal of the British Diabetic Association|September 1, 1985
Platelet aggregation in diabetics using the new electronic platelet aggregometerD P Mikhailidis, M A Barradas, P Dandona
Journal of Clinical Pathology|March 1, 1986
Fibrinogen mediated activation of platelet aggregationD P Mikhailidis, M A Barradas, P Dandona
Journal of the Royal Society of Medicine|January 1, 1987
Cardiovascular risk in patients with treated familial hypercholesterolaemia and patients with severe hypertriglyceridaemiaD P Mikhailidis, M A Barradas, P Dandona
Thrombosis and Haemostasis|December 17, 1985
Dihomo-gamma-linolenic acid in patients with atherosclerosis: effects on platelet aggregation, plasma lipids and low-density lipoprotein-induced inhibition of prostacyclin generationD P Mikhailidis, M A Barradas, P Dandona
In Vivo (Athens, Greece)|November 1, 1992
Measurement of platelet volume using a channelyzer: assessment of the effect of agonists and antagonistsM A Barradas, S O'Donoghue, D P Mikhailidis
Diabetes Research and Clinical Practice|January 1, 1987
The effect of non-esterified fatty acids on vascular ADP-degrading enzyme activityM A Barradas, D P Mikhailidis, P Dandona
British Journal of Clinical Pharmacology|February 1, 1996
A low molecular weight heparin, nadroparin (Fraxiparine), inhibits thrombin-induced platelet shape change and does not enhance spontaneous platelet aggregationI A Jagroop, M A Barradas, D P Mikhailidis
Platelets|November 4, 2010
Platelet hyperactivity: a predictor of cardiac events and death from myocardial infarctionD P Mikhailidis, M A Barradas, J Y Jeremy
Pageof 11